Induction of tolerance via the sublingual route: Mechanisms and applications

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Moingeon, Philippe ^a   Mascarell, Laurent ^a  

^a Stallergnes SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; GRASS POLLEN VACCINE; HOUSE DUST ALLERGEN; INTERLEUKIN 10; ORALAIR; PHOSPHORYL LIPID A; PLACEBO; POLLEN ANTIGEN; RECOMBINANT ALLERGEN; RECOMBINANT BET V 1 ALLERGEN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VACCINE;

ALLERGIC ASTHMA; ALLERGY; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; BONE MARROW CELL; CD4+ T LYMPHOCYTE; DENDRITIC CELL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; EAR PRURITUS; EGG ALLERGY; EOSINOPHIL; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; LAMINA PROPRIA; LANGERHANS CELL; LYMPHOCYTE DIFFERENTIATION; MAST CELL; MILK ALLERGY; MITE ALLERGY; MUCOSA; PEANUT ALLERGY; PERENNIAL RHINITIS; PLASMACYTOID DENDRITIC CELL; POLLEN ALLERGY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; RHINOCONJUNCTIVITIS; SUBLINGUAL IMMUNOTHERAPY; SUBMUCOSA; TH1 CELL; TH17 CELL; TH2 CELL; THROAT IRRITATION; TONGUE EDEMA; TREATMENT INDICATION; VENOM ALLERGY; ANIMAL; DESENSITIZATION; HYPERSENSITIVITY; IMMUNOLOGY; MOUTH MUCOSA; MUCOSAL IMMUNITY; SUBLINGUAL DRUG ADMINISTRATION;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; ANIMALS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; MOUTH MUCOSA; VACCINES;

EID: 84855162428     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/623474     Document Type: Review

References (70)

1. Noon L., Prophylactic inoculation against hay fever The Lancet 1911 177 4580 1572 1573
2. Freeman J., Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine The Lancet 1911 178 4594 814 817
3. Bousquet J., Lockey R., Malling H. J., Alvarez-Cuesta E., Canonica G. W., Chapman M. D., Creticos P. J., Dayer J. M., Durham S. R., Demoly P., Goldstein R. J., Ishikawa T., Ito K., Kraft D., Lambert P. H., Lwenstein H., Mller U., Norman P. S., Reisman R. E., Valenta R., Valovirta E., Yssel H., Allergen immunotherapy: therapeutic vaccines for allergic diseasesa WHO position paper Journal of Allergy and Clinical Immunology 1998 102 4 558 562
4. Cox L., Li J. T., Nelson H., Lockey R., Allergen immunotherapy: a practice parameter second update Journal of Allergy and Clinical Immunology 2007 120 3 S25 S85
5. Canonica G. W., Passalacqua G., Noninjection routes for immunotherapy Journal of Allergy and Clinical Immunology 2003 111 3 437 448 (Pubitemid 36337857)
6. Canonica G. W., Bousquet J., Casale T., Lockey R. F., Baena-Cagnani C. E., Pawankar R., Potter P. C., Bousquet P. J., Cox L. S., Durham S. R., Nelson H. S., Passalacqua G., Ryan D. P., Brozek J. L., Compalati E., Dahl R., Delgado L., van Wijk R. G., Gower R. G., Ledford D. K., Filho N. R., Valovirta E. J., Yusuf O. M., Zuberbier T., Akhanda W., Almarales R. C., Ansotegui I., Bonifazi F., Ceuppens J., Chivato T., Dimova D., Dumitrascu D., Luigi Fontana, Katelaris C. H., Kaulsay R., Kuna P., Larenas-Linnemann D., Manoussakis M., Nekam K., Nunes C., OHehir R., MOlaguibel J., Onder N. B., Won Park J., Priftanji A., Puy R., Sarmiento L., Scadding G., Schmid-Grendelmeier P., Seberova E., Sepiashvili R., Sole D., Togias A., Tomino C., Toskala E., van Beever H., Vieths S., Sub-lingual immunotherapy: world allergy organization position paper 2009 Allergy 2009 64 91 1 59
7. Passalacqua G., Lombardi C., Troise C., Canonica G. W., Sublingual immunotherapy: certainties, unmet needs and future directions European Annals of Allergy and Clinical Immunology 2009 41 6 163 170
8. Frew A. J., How does sublingual immunotherapy work? Journal of Allergy and Clinical Immunology 2007 120 3 533 536 (Pubitemid 47320776)
9. Mayer L., Shao L., Therapeutic potential of oral tolerance Nature Reviews Immunology 2004 4 6 407 419 (Pubitemid 38745553)
10. Mowat A. M. I., Parker L. A., Beacock-Sharp H., Millington O. R., Chirdo F., Oral tolerance: overview and historical perspectives Annals of the New York Academy of Sciences 2004 1029 1 8 (Pubitemid 40298509)
11. Faria A. M. C., Weiner H. L., Oral tolerance Immunological Reviews 2005 206 232 259 (Pubitemid 41105174)
12. Urbanek R., Burgelin K. H., Kahle S., Kuhn W., Wahn U., Oral immunotherapy with grass pollen in enterosoluble capsules. A prospective study of the clinical and immunological response European Journal of Pediatrics 1990 149 8 545 550 (Pubitemid 20184015)
13. Moller C., Dreborg S., Lanner A., Bjorksten B., Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. A double blind study Allergy 1986 41 4 271 279 (Pubitemid 16039032)
14. Taudorf E., Laursen L. C., Lanner A., Oral immunotherapy in birch pollen hay fever Journal of Allergy and Clinical Immunology 1987 80 2 153 161 (Pubitemid 17131082)
15. Deuschl H., Johansson S. G. O., Hyposensitization of patients with allergic rhinitis by intranasal administration of chemically modified grass pollen allergen. A pilot study Acta Allergologica 1977 32 4 248 262 (Pubitemid 8134729)
16. Nickelsen J. A., Goldstein S., Mueller U., Local intranasal immunotherapy for ragweed allergic rhinitis. I. Clinical response Journal of Allergy and Clinical Immunology 1981 68 1 33 40 (Pubitemid 11079115)
17. Georgitis J. W., Reisman R. E., Clayton W. F., Local intranasal immunotherapy for grass-allergic rhinitis Journal of Allergy and Clinical Immunology 1983 71 1 I 71 76 (Pubitemid 13183906)
18. Senti G., Freiburghaus A. U., Kundig T. M., Epicutaneous/transcutaneous allergen-specific immunotherapy: rationale and clinical trials Current Opinion in Allergy and Clinical Immunology 2010 10 6 582 586
19. Dioszeghy V., Mondoulet L., Dhelft V., Ligouis M., Puteaux E., Benhamou P.-H., Dupont C., Epicutaneous immunotherapy results in rapid allergen uptake by dendritic cells through intact skin and downregulates the allergen-specific response in sensitized mice Journal of Immunology 2011 186 10 5629 5637
20. Senti G., Prinz Vavricka B. M., Erdmann I., Diaz M. I., Markus R., McCormack S. J., Simard J. J., Wthrich B., Crameri R., Graf N., Johansen P., Kndig T. M., Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial Proceedings of the National Academy of Sciences of the United States of America 2008 105 46 17908 17912
21. Moingeon P., Batard T., Fadel R., Frati F., Sieber J., van Overtvelt L., Immune mechanisms of allergen-specific sublingual immunotherapy Allergy 2006 61 2 151 165 (Pubitemid 43381824)
22. Moingeon P., Sublingual immunotherapy: from biological extracts to recombinant allergens Allergy 2006 61 81 15 19
23. Wilson D. R., Lima M. T., Durham S. R., Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis Allergy 2005 60 1 4 12
24. Calamita Z., Saconato H., Pel A. B., Atallah A. N., Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method Allergy 2006 61 10 1162 1172 (Pubitemid 44326350)
25. Penagos M., Passalacqua G., Compalati E., Baena-Cagnani C. E., Orozco S., Pedroza A., Canonica G. W., Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age Chest 2008 133 3 599 609 (Pubitemid 351367366)
26. Penagos M., Compalati E., Tarantini F., Baena-Cagnani R., Huerta J., Passalacqua G., Canonica G. W., Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials Annals of Allergy, Asthma and Immunology 2006 97 2 141 148 (Pubitemid 44272577)
27. Pipet A., Botturi K., Pinot D., Vervloet D., Magnan A., Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy Respiratory Medicine 2009 103 6 800 812
28. Dahl R., Kapp A., Colombo G., de Monchy J. G. R., Rak S., Emminger W., Rivas M. F., Ribel M., Durham S. R., Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis Journal of Allergy and Clinical Immunology 2006 118 2 434 440 (Pubitemid 44160721)
29. Didier A., Malling H. J., Worm M., Horak F., Jger S., Montagut A., André C., de Beaumont O., Melac M., Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis Journal of Allergy and Clinical Immunology 2007 120 6 1338 1345 (Pubitemid 350225683)
30. Batard T., Hrabina A., Xue Z. B., Chabre H., Lemoine P., Couret M. N., Faccenda D., Villet B., Harzic P., André F., Sock Y. G., André C., Fook T. C., Moingeon P., Production and proteomic characterization of pharmaceutical-grade Dermatophagoides pteronyssinus and Dermatophagoides farinae extracts for allergy vaccines International Archives of Allergy and Immunology 2006 140 4 295 305 (Pubitemid 44114474)
31. Marogna M., Spadolini I., Massolo A., Canonica G. W., Passalacqua G., Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study Journal of Allergy and Clinical Immunology 2010 126 5 969 975
32. Durham S. R., Emminger W., Kapp A., Colombo G., de Monchy J. G. R., Rak S., Scadding G. K., Andersen J. S., Riis B., Dahl R., Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet Journal of Allergy and Clinical Immunology 2010 125 13 131 138
33. Mascarell L., Lombardi V., Louise A., Saint-Lu N., Chabre H., Moussu H., Betbeder D., Balazuc A. M., van Overtvelt L., Moingeon P., Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells Journal of Allergy and Clinical Immunology 2008 122 3 603 609
34. Mascarell L., Lombardi V., Zimmer A., Louise A., Tourdot S., van Overtvelt L., Moingeon P., Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells Clinical and Experimental Allergy 2009 39 12 1910 1919
35. Novak N., Haberstok J., Bieber T., Allam J. P., The immune privilege of the oral mucosa Trends in Molecular Medicine 2008 14 5 191 198
36. Allam J. P., Wrtzen P. A., Reinartz M., Winter J., Vrtala S., Chen K. W., Valenta R., Wenghoefer M., Appel T., Gros E., Niederhagen B., Bieber T., Lund K., Novak N., Phl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF- 1 and IL-10-producing properties Journal of Allergy and Clinical Immunology 2010 126 3 638 645
37. Allam J.-P., Novak N., Fuchs C., Asen S., Bergé S., Appel T., Geiger E., Kochan J. P., Bieber T., Characterization of dendritic cells from human oral mucosa: a new Langerhans' cell type with high constitutive Fc RI expression Journal of Allergy and Clinical Immunology 2003 112 1 141 148 (Pubitemid 36819819)
38. Allam J. P., Stojanovski G., Friedrichs N., Peng W., Bieber T., Wenzel J., Novak N., Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy 2008 63 6 720 727 (Pubitemid 351591847)
39. Mascarell L., Saint Lu N., Moussu H., A role for oral macrophage-like cells in establishing tolerance following sublingual immunization. Mucosal Immunology. In press
40. Czerkinsky C., uburu N., Kweon M.-N., Anjuere F., Holmgren J., Sublingual vaccination Human Vaccines 2011 7 1 110 114
41. Larché M., Akdis C. A., Valenta R., Immunological mechanisms of allergen-specific immunotherapy Nature Reviews Immunology 2006 6 10 761 771 (Pubitemid 44453462)
42. Jutel M., Akdis M., Blaser K., Akdis C. A., Mechanisms of allergen specific immunotherapyt-cell tolerance and more Allergy 2006 61 7 796 807 (Pubitemid 43893981)
43. Scadding G., Durham S., Mechanisms of sublingual immunotherapy Journal of Asthma 2009 46 4 322 334
44. van Neerven R. J. J., Wikborg T., Lund G., Jacobsen B., Brinch-Nielsen., Arnved J., Ipsen H., Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation Journal of Immunology 1999 163 5 2944 2952 (Pubitemid 29399227)
45. Wachholz P. A., Durham S. R., Induction of blocking IgG antibodies during immunotherapy Clinical and Experimental Allergy 2003 33 9 1171 1174 (Pubitemid 37108518)
46. Bahceciler N. N., Arikan C., Taylor A., Akdis M., Blaser K., Barlan I. B., Akdis C. A., Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites International Archives of Allergy and Immunology 2005 136 3 287 294 (Pubitemid 40529201)
47. Razafindratsita A., Saint-Lu N., Mascarell L., Berjont N., Bardon T., Betbeder D., van Overtvelt L., Moingeon P., Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation Journal of Allergy and Clinical Immunology 2007 120 2 278 285 (Pubitemid 47411528)
48. Durham S. R., Varney V. A., Gaga M., Jacobson M. R., Varga E. M., Frew A. J., Kay K. B., Grass pollen immunotherapy decreases the number of mast cells in the skin Clinical and Experimental Allergy 1999 29 11 1490 1496 (Pubitemid 29519278)
49. Wilson D. R., Irani A. M., Walker S. M., Jacobson M. R., Mackay I. S., Schwartz L. B., Durham S. R., Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium Clinical and Experimental Allergy 2001 31 11 1705 1713 (Pubitemid 34204427)
50. Iliopoulos O., Proud D., Adkinson N. F., Creticos P. S., Norman P. S., Kagey-Sobotka A., Lichtenstein L. M., Naclerio R. M., Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells Journal of Allergy and Clinical Immunology 1991 87 4 855 866
51. Ciprandi G., Fenoglio D., Cirillo I., Vizzaccaro A., Ferrera A., Tosca M. A., Puppo F., Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report Annals of Allergy, Asthma and Immunology 2005 95 1 38 44 (Pubitemid 41022771)
52. Bohle B., Kinaciyan T., Gerstmayr M., Radakovics A., Jahn-Schmid B., Ebner C., Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation Journal of Allergy and Clinical Immunology 2007 120 3 707 713 (Pubitemid 47320765)
53. Valenta R., The future of antigen-specific immunotherapy of allergy Nature Reviews Immunology 2002 2 6 446 453 (Pubitemid 37328752)
54. Batard T., Didierlaurent A., Chabre H., Mothes N., Bussires L., Bohle B., Couret M. N., Ball T., Lemoine P., Tejkl M. F., Chenal A., Clément G., Dupont F., Valent P., Krauth M. T., André C., Valenta R., Moingeon P., Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy International Archives of Allergy and Immunology 2005 136 3 239 249 (Pubitemid 40529195)
55. Pauli G., Larsen T. H., Rak S., Horak F., Pastorello E., Valenta R., Purohit A., Arvidsson M., Kavina A., Schroeder J. W., Mothes N., Spitzauer S., Montagut A., Galvain S., Melac M., André C., Poulsen L. K., Malling H. J., Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis Journal of Allergy and Clinical Immunology 2008 122 5 951 960
56. Larenas-Linnemann D., Oralair Birch, a recombinant major birch pollen allergen tablet for sublingual immunotherapy of allergic rhinitis caused by birch pollen Current Opinion in Investigational Drugs 2010 11 5 586 596
57. Moingeon P., Lombardi V., Saint-Lu N., Tourdot S., Bodo V., Mascarell L., Adjuvants and vector systems for allergy vaccines Immunology and Allergy Clinics of North America 2011 31 2 407 419
58. Mascarell L., van Overtvelt L., Lombardi V., Razafindratsita A., Moussu H., Horiot S., Chabre H., Limal D., Moutel S., Bauer J., Chiavaroli C., Moingeon P., A synthetic triacylated pseudo-dipeptide molecule promotes Th1/TReg immune responses and enhances tolerance induction via the sublingual route Vaccine 2007 26 1 108 118 (Pubitemid 350213205)
59. Lombardi V., van Overtvelt L., Horiot S., Moussu H., Chabre H., Louise A., Balazuc A.-M., Mascarell L., Moingeon P., Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route Clinical and Experimental Allergy 2008 38 11 1819 1829
60. van Overtvelt L., Lombardi V., Razafindratsita A., Saint-Lu N., Horiot S., Moussu H., Mascarell L., Moingeon P., IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model International Archives of Allergy and Immunology 2008 145 2 152 162
61. van Overtvelt L., Moussu H., Horiot S., Samson S., Lombardi V., Mascarell L., van de Moer A., Bourdet-Sicard R., Moingeon P., Lactic acid bacteria as adjuvants for sublingual allergy vaccines Vaccine 2010 28 17 2986 2992
62. Pfaar O., Barth C., Jaschke C., Hrmann K., Klimek L., Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: a phase I/IIa study International Archives of Allergy and Immunology 2010 154 4 336 344
63. Saint-Lu N., Tourdot S., Razafindratsita A., Mascarell L., Berjont N., Chabre H., Louise A., van Overtvelt L., Moingeon P., Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction Allergy 2009 64 7 1003 1013
64. Mller C., Dreborg S., Ferdousi H. A., Halken S., Host A., Jacobsen L., Koivikko A., Koller D. Y., Niggemann B., Norberg L. A., Urbanek R., Valovirta E., Wahn U., Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-Study) Journal of Allergy and Clinical Immunology 2002 109 2 251 256 (Pubitemid 34158289)
65. Bousquet J., Scheinmann P., Guinnepain M. T., Perrin-Fayolle M., Sauvaget J., Tonnel A. B., Pauli G., Caillaud D., Dubost R., Leynadier F., Vervloet D., Herman D., Galvain S., André C., Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study Allergy 1999 54 3 249 260 (Pubitemid 29185286)
66. Pajno G. B., Morabito L., Barberio G., Parmiani S., Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study Allergy 2000 55 9 842 849 (Pubitemid 30643909)
67. Passalacqua G., Compalati E., Canonica G. W., Sublingual Immunotherapy: other Indications Immunology and Allergy Clinics of North America 2011 31 2 279 287
68. Fernndez-Rivas M., Garrido Fernndez S., Nadal J. A., De Durana M. D. A. D., Garca B. E., Gonzlez-Mancebo E., Martn S., Barber D., Rico P., Tabar A. I., Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract Allergy 2009 64 6 876 883
69. Enrique E., Pineda F., Malek T., Bartra J., Basagaa M., Tella R., Castell J. V., Alonso R., De Mateo J. A., Cerd-Trias T., San Miguel-Moncn M. D. M., Monzn S., Garca M., Palacios R., Cister-Bahma A., Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract Journal of Allergy and Clinical Immunology 2005 116 5 1073 1079 (Pubitemid 41571791)
70. Pajno G. B., Caminiti L., Vita D., Barberio G., Salzano G., Lombardo F., Canonica G. W., Passalacqua G., Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study Journal of Allergy and Clinical Immunology 2007 120 1 164 170 (Pubitemid 46990495)